Home  >  Research  >  Labs  >  Cancer Program  >  LIVER DISEASE AND CARCINOGENESIS

RESEARCH OVERVIEW

This Liver Disease and Carcinogenesis group focuses on the biology of the liver progenitor cell (LPC) called an “oval cell” which describes its shape. We envisage an enormous potential for LPCs as the vehicle for cell and gene therapy to treat liver disease. Liver progenitor cells are superior to other cells such as hepatocytes and embryonic (ESC) or adult stem cells (ASC) for many reasons. In particular, LPCs are robust and simple to freeze and store, they can then be thawed and grown by in vitro culture when required. They are more versatile than hepatocytes as they are easily and rapidly differentiated into either hepatocytes or cholangiocytes (bile duct cells) when maintained under appropriate conditions. Most importantly, the LPC is developmentally close to the hepatocyte and the cholangiocyte, in contrast to the ESC or ASC, which will require many more steps and much coaxing to produce useful cells for liver therapy.

Our long-term vision is to hasten the day when human LPCs are used to treat liver disease, especially end-stage liver disease for which currently organ transplant is the only solution. A realistic expectation in the short term is to use LPCs to “bridge” patients by extending their survival and enhancing their chances of finding a suitable organ donor. A more ambitious and longer-term aim is to use these cells to circumvent the requirement for organ transplant. This may be possible with some liver diseases.

Professor Yeoh recently gave a lecture about the rising incidence of liver cancer. Liver cancer is the fastest growing cancer threat in Australia, since 1984 incidence and mortality rates have doubled in Australian men and women. Watch Professor Yeoh’s seminar below.

Professor George Yeoh

Professor George Yeoh

Liver Disease and Carcinogenesis

Read more

LATEST NEWS

Why walk 35kms when you could walk 70?

Breast cancer survivor pushes herself to say thank you Four years clear of cancer, Connie Nicoletti-Lewins is committed to supporting the people who work to solve cancer’s mysteries and develop new treatments. Inspired by Perth’s annual Walk for Women’s Cancer that raises funds for cancer researchers at the Harry Perkins…

Read More

Bioinformatics and high-performance computing evolution lead to better treatments for major diseases

It’s time to talk about bioinformatics and its influence on high-performance computing (HPC) as well as the importance of data analysis and interpretation in medical research. As part of Data Science Week events, 10-14 May, Perkins' bioinformatician Dr Elena Denisenko will join Dr Stuart Midgely, DUG CIO, physicist and high-performance…

Read More

Moorditj Mob walking to support cancer research

Indigenous medical scientist Danielle Headland is choosing to honour her late mother by supporting Perth’s Walk for Women’s Cancer to help cancer researchers find new treatments and solve the mysteries of the disease that claimed her mother’s life. Danielle’s mother succumbed to uterine cancer in 2013, two years after diagnosis.…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS